Published date: 9 September 2024
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Research and development consultancy services - 73200000
Location of contract
SW1H 0EU
Value of contract
£248,264
Procurement reference
CF-2581200D0O000000rwimUAA
Published date
9 September 2024
Closing date
21 October 2024
Closing time
12pm
Contract start date
10 December 2024
Contract end date
9 November 2025
Contract type
Service contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.
This contract has been divided into 4 lots. Each lot corresponds to the following lots
Lot 1 Biliary atresia
Lot 2 Group B strep
Lot 3 Breast Risk Stratification
Lot 4 Targeted Screening
Contract Project Reference: C294820
Contract term: 9 months with the option to extend for up to further 2 months.
Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)
The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.
To find this opportunity in the eTendering system, select "Find Opportunities" and then search by project number or title. Once you have found the Opportunity, press the 'Register Interest' button to register your interest. This will make the project to appear on 'My proposals and quotes'. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.
Deadline for submission: 21st October 2024 at 12 noon
More information
Additional text
-
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
About the buyer
Contact name
Jay Bains
Address
Victoria Street
London
SW1H 0EU
GB
Telephone
01132045540
Share this notice
Closing: 21 October 2024, 12pm
All content is available under the
